Atlas Trials

Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

Clinical trial NCT03963024 · TERMINATED

Trial details

NCT number
NCT03963024
Sponsor
IRCCS San Raffaele
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Irradiated Bone MarrowTransplant-Related Hematologic MalignancyLeukemia, AcuteMultiple MyelomaGraft Vs Host Disease
Start date
2014-02-12
Primary completion
2019-01-31
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.